Mevion to install S250 proton therapy system at MedStar Georgetown Hospital

7 September 2014 (Last Updated September 7th, 2014 18:30)

Mevion Medical Systems is set to install its MEVION S250 proton therapy system at the MedStar Georgetown University Hospital, located in Northwest Washington, Columbia, US, to treat adult and paediatric cancer patients.

mevion

Mevion Medical Systems is set to install its MEVION S250 proton therapy system at the MedStar Georgetown University Hospital, north-west Washington, Columbia, US, to treat adult and paediatric cancer patients.

MedStar has secured final approval to start construction of the proton therapy centre at its Lombardi Comprehensive Cancer Center.

The MEVION S250 device delivers precise, non-invasive treatment advantages and capabilities with a significantly reduced footprint, improved reliability, more efficient patient access, and dramatically lower implementation and operational costs.

Proton therapy is an advanced form of external radiation treatment for different cancers in sensitive areas such as central nervous system, chest, head and neck, eye and prostate.

MedStar intends to begin the construction of the centre this autumn, while the system installation is expected to be complete in 2016.

"Proton therapy is an advanced form of external radiation treatment for different cancers in sensitive areas such as central nervous system, chest, head and neck, eye and prostate."

MedStar Georgetown University Hospital president Richard Goldberg said: "The addition of proton therapy to our experienced and internationally known cancer programme is a natural progression for us as the only provider in the region with a long history of serving both children as well as adults with cancer.

"We are excited to bring this important technology to our community and to give our patients yet another cutting-edge cancer treatment option."

Mevion Medical Systems president and CEO Joseph Jachinow said: "The MEVION S250 proton therapy system provides a significant benefit to cancer patients while redefining the economics and accessibility of proton therapy."

The company has also installed the system at the Kling Proton Therapy Center at Barnes-Jewish Hospital in Washington University of St Louis, Missouri.

In addition, the systems are being installed at Robert Wood Johnson University Hospital in New Jersey, Stephenson Cancer Center at the University of Oklahoma, First Coast Oncology in Florida, University of Florida Health Cancer Center at Orlando Health and University Hospitals Seidman Cancer Center in Ohio.


Image: The MEVION S250 provides the benefits of proton therapy without the size, complexity and cost of traditional proton therapy treatments. Photo: courtesy of Business Wire.